Skip to content

All best practices

CS-162mixed

Fevertree Drinks plc (Fever-Tree), London-based premium mixer brand listed on AIM, which outsources its bottling

US expansion with local US bottling, followed by a margin-rebuild programme for the supply chain and the hand-over of US production and distribution to Molson Coors (2019-2025)

Region
Western Europe, North America
Country
United Kingdom, United States
Industry
Food and Beverage Manufacturing
Functions
Supply Chain & Logistics, Procurement & Strategic Sourcing, Manufacturing & Production, Finance & FP&A, Sales & Revenue Operations
Topics
Margins are eroding despite revenue; Supply chain disruption has made the network fragile; Supplier inflation and procurement leakage are unsustainable; Energy, resource or climate exposure undermines economics
Starting situation
New initiative
Period
2019–2025
Last verified
5 November 2026

Executive summary

Fever-Tree, a London mixer brand that owns no factories and has its drinks bottled by partners, set out in 2018-2019 to grow in the United States and to bottle there rather than ship glass bottles across the Atlantic [C01, C02, C05]. US sales nearly tripled in five years [C01, C19].

The supply chain did not keep pace. Glass, energy and freight costs rose, US bottling ramped slowly, the West Coast contract was not renewed, and gross margin fell from 50.5% to 32.1% in four years [C01, C11, C14, C15]. In 2025 the company handed US production, distribution and sales to Molson Coors, and most US product was still made in Britain [C17, C22].

The numbers that matter: US revenue £47.6m (2019) to £128.0m (2024) [C01, C19]; adjusted EBITDA £77.0m (2019) to £30.5m (2023) and £50.7m (2024) [C01, C14, C19]. The lesson: an asset-light brand that moves production to a new market must secure the co-packing capacity and the cost base there before demand outruns them.

Outcome: mixed

Documented shortfalls or reversals sit alongside documented gains. For example: an initial failure later recovered, or a strategic goal met while a major adverse event in the same programme was recorded.

Basis of the outcome

Gains: US revenue rose from £47.6m (2019) to £128.0m (2024), making the US the largest region, and the brand became the leading US tonic by value at retail (S01, S03, S13). Shortfalls: gross margin fell from 50.5% (2019) to 32.1% (2023) and adjusted EBITDA from £77.0m to £30.5m (S01, S09); 2023 guidance was cut from £36-42m to about £30-36m (S08); the March 2024 guidance of an adjusted EBITDA margin of about 15% and a gross-margin gain of about 600bps ended at 13.7% and 540bps (S09, S13). The US bottling network was cut back: the West Coast contract was not renewed (S09), US stock affected by production issues was quarantined and fully provided for (S07), and in 2025 most US product was made in Britain after US production and distribution passed to Molson Coors (S12, S15). Documented gains alongside documented shortfalls and a reversal meet the mixed criterion.

Key figures

PhaseFigureValueWhenVerification
BeforeRevenue£260.5m2019audited_filing
BeforeUS revenue£47.6m2019audited_filing
BeforeGross margin50.5%2019audited_filing
BeforeAdjusted EBITDA£77.0m2019audited_filing
DuringWest Coast line in productionDec 20202020company_reported
DuringProfit guidance cut£63m-66m to £37.5m-45mJul 2022press_reported
DuringUS inventory provided for£3.3mH1 2023company_reported
AfterGross margin (low point)32.1%2023audited_filing
AfterAdjusted EBITDA (low point)£30.5m2023audited_filing
AfterUS revenue£128.0m2024audited_filing
AfterUS share of group profitabout 2%2023press_reported
AfterMolson Coors stake8.5% for £71mJan 2025multiple_independent
audited_filing
A figure in audited financial statements, such as an annual report's financial statements or a 10-K.
company_reported
A company statement, press release or investor presentation that no one has independently checked.
press_reported
A journalist's own reporting.
multiple_independent
Two or more independent sources agree.

Sources

  1. S01 Fevertree Drinks plc: Preliminary Results (year to 31 December 2019) · Fevertree Drinks plc, London Stock Exchange RNS (via lse.co.uk), 2020-04-22 · accessed 2026-11-04
  2. S02 Fevertree Drinks plc: FY20 Preliminary Results to 31 December 2020 · Fevertree Drinks plc, London Stock Exchange RNS (via lse.co.uk), 2021-03-18 · accessed 2026-11-04
  3. S03 Fevertree Drinks plc: FY21 Preliminary Results to 31 December 2021 · Fevertree Drinks plc, London Stock Exchange RNS (via lse.co.uk), 2022-03-16 · accessed 2026-11-04
  4. S04 Fever-Tree slashes profit forecast over surging costs and staff shortages · Jacqui Parr, Grocery Gazette, 2022-07-15 · accessed 2026-11-04
  5. S05 Fever-Tree profit falls 30% after being hit by rising costs · Mark Wembridge, The Irish Times (Financial Times content), 2022-09-13 · accessed 2026-11-04
  6. S06 Fevertree Drinks plc: FY22 Preliminary Results to 31 December 2022 · Fevertree Drinks plc, Investegate (RNS), 2023-03-22 · accessed 2026-11-04
  7. S07 Fevertree Drinks plc: Fever-Tree FY23 Interim Results - Replacement · Fevertree Drinks plc, London Stock Exchange RNS (via lse.co.uk), 2023-09-12 · accessed 2026-11-04
  8. S08 Fever-Tree cuts revenue, profit forecasts · Dean Best, Just Drinks, 2023-09-12 · accessed 2026-11-04
  9. S09 Fevertree Drinks plc: FY23 Preliminary Results to 31 December 2023 · Fevertree Drinks plc, London Stock Exchange RNS (via lse.co.uk), 2024-03-26 · accessed 2026-11-04
  10. S10 ii view: confident Fevertree shrugs off profit slump · Keith Bowman, interactive investor, 2024-03-26 · accessed 2026-11-04
  11. S11 Fever-Tree sells £71m stake to Molson Coors · William Dodds, Food Manufacture, 2025-01-30 · accessed 2026-11-04
  12. S12 Fevertree to launch share buyback as part of US distribution deal · Emily Parsons (Alliance News), Morningstar UK (Alliance News), 2025-01-30 · accessed 2026-11-04
  13. S13 Fevertree Drinks FY24 Preliminary Results · Fevertree Drinks plc, James Sharp & Co (copy of the RNS), 2025-03-25 · accessed 2026-11-04
  14. S14 Fever-Tree confident on FY25 outlook despite US tariffs · Yasmeen Louis, Grocery Gazette, 2025-06-05 · accessed 2026-11-04
  15. S15 Fevertree Drinks' first-half pretax profit falls 15% on US margin pressure · Reuters, RTÉ News (Reuters), 2025-09-11 · accessed 2026-11-04

Researched and fact-checked knowledgebase · Knowledgebase built 5 November 2026 · Last verified 5 November 2026

Practices, their evidence grades and case summaries are public. Full case studies are available in AXIOM to subscribers and AXIOM Discover participants.